Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...

LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...

A study using agentic artificial intelligence to detect early signs of cognitive decline in unstructured m | Mass General ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...

Patient sleeps with the patient-applied Onera home Polysomnography (Onera hPSG) solution. The international multicenter study ...

SELLAS Life Sciences Group (SLS) has entered an agreement with IMPACT-AML, a pan-European clinical network, to run a new ...

Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than ...

New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...

VapeAway® LLC, a healthcare company focused on developing innovative solutions for nicotine dependence due to vaping, today announced that the first patient has been enrolled in its clinical study ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

Dr. Lei Qian, Vice President of Clinical Development of Innovent, stated, "We are delighted that the results of the Phase 3 study DREAMS-2 for mazdutide in T2D will be presented in the form of a ...